BioCentury
ARTICLE | Clinical News

Pimagedine: Started Phase II trial in 120 patients on dialysis

January 8, 1996 8:00 AM UTC

Alteon Inc. (ALTN), Ramsey, N.J. Product: Pimagedine, blocker of abnormal glucose/protein complexes Indication: Type I and II diabetics with end-stage renal disease Status: Started Phase II trial in 1...